{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T07:54:55Z","timestamp":1794210895496,"version":"4.8.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-024-13230-5","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T03:01:06Z","timestamp":1739847666000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Financial toxicity questionnaire (FIT): development and validation of the italian version (FITALY) in head and neck cancer patients undergoing multimodal curative treatment"],"prefix":"10.1186","volume":"25","author":[{"given":"Davide","family":"Smussi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Lorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Mattavelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosella","family":"Levaggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Miniaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Calza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Deganello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Consiglia","family":"Paduano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Alberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Grisanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla Ida","family":"Ripamonti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Berruti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Piazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Bossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,18]]},"reference":[{"issue":"6","key":"13230_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"13230_CR2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1056\/NEJMra1715715","volume":"382","author":"LQM Chow","year":"2020","unstructured":"Chow LQM. Head and Neck Cancer. N Engl J Med. 2020;382(1):60\u201372.","journal-title":"N Engl J Med"},{"issue":"2","key":"13230_CR3","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3322\/caac.21443","volume":"68","author":"PM Carrera","year":"2018","unstructured":"Carrera PM, Kantarjian HM, Blinder VS. The financial burden and distress of patients with cancer: understanding and stepping-up action on the financial toxicity of cancer treatment. CA Cancer J Clin. 2018;68(2):153\u201365.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"13230_CR4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1001\/jamaoto.2018.3982","volume":"145","author":"ST Massa","year":"2019","unstructured":"Massa ST, Osazuwa-Peters N, Adjei Boakye E, Walker RJ, Ward GM. Comparison of the Financial Burden of survivors of Head and Neck Cancer with Other Cancer survivors. JAMA Otolaryngol Head Neck Surg. 2019;145(3):239\u201349.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"13230_CR5","doi-asserted-by":"publisher","first-page":"105196","DOI":"10.1016\/j.oraloncology.2021.105196","volume":"115","author":"SJ Ma","year":"2021","unstructured":"Ma SJ, Iovoli AJ, Attwood K, Wooten KE, Arshad H, Gupta V, et al. Association of significant financial burden with survival for head and neck cancer patients treated with radiation therapy. Oral Oncol. 2021;115:105196.","journal-title":"Oral Oncol"},{"key":"13230_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.annepidem.2021.01.004","volume":"57","author":"S Shariff-Marco","year":"2021","unstructured":"Shariff-Marco S, DeRouen MC, Yang J, Jain J, Nelson DO, Weden MM, et al. Neighborhood archetypes and breast cancer survival in California. Ann Epidemiol. 2021;57:22\u20139.","journal-title":"Ann Epidemiol"},{"key":"13230_CR7","unstructured":"The Harris Poll. ASCO 2018 Cancer Opinions Surveys. 2018."},{"issue":"3","key":"13230_CR8","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1200\/JCO.2015.62.0468","volume":"34","author":"KR Yabroff","year":"2016","unstructured":"Yabroff KR, Dowling EC, Guy GP, Banegas MP, Davidoff A, Han X, et al. Financial Hardship Associated with Cancer in the United States: findings from a Population-based sample of Adult Cancer survivors. J Clin Oncol. 2016;34(3):259\u201367.","journal-title":"J Clin Oncol"},{"issue":"3","key":"13230_CR9","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/cncr.30369","volume":"123","author":"JA de Souza","year":"2017","unstructured":"de Souza JA, Yap BJ, Wroblewski K, Blinder V, Ara\u00fajo FS, Hlubocky FJ, et al. Measuring financial toxicity as a clinically relevant patient-reported outcome: the validation of the COmprehensive score for financial toxicity (COST). Cancer. 2017;123(3):476\u201384.","journal-title":"Cancer"},{"issue":"6","key":"13230_CR10","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1007\/s00520-018-4498-1","volume":"27","author":"M B\u00fcttner","year":"2019","unstructured":"B\u00fcttner M, K\u00f6nig HH, L\u00f6bner M, Briest S, Konnopka A, Dietz A, et al. Out-of-pocket-payments and the financial burden of 502 cancer patients of working age in Germany: results from a longitudinal study. Support Care Cancer. 2019;27(6):2221\u20138.","journal-title":"Support Care Cancer"},{"key":"13230_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/JGO.19.11000","volume":"5","author":"K Honda","year":"2019","unstructured":"Honda K, Gyawali B, Ando M, Kumanishi R, Kato K, Sugiyama K, et al. Prospective survey of Financial Toxicity measured by the Comprehensive score for financial toxicity in Japanese patients with Cancer. J Glob Oncol. 2019;5:1\u20138.","journal-title":"J Glob Oncol"},{"key":"13230_CR12","doi-asserted-by":"publisher","first-page":"1329242","DOI":"10.3389\/fonc.2024.1329242","volume":"14","author":"J Rast","year":"2024","unstructured":"Rast J, Zebralla V, Dietz A, Wichmann G, Wiegand S. Cancer-associated financial burden in German head and neck cancer patients. Front Oncol. 2024;14:1329242.","journal-title":"Front Oncol"},{"issue":"17","key":"13230_CR13","doi-asserted-by":"publisher","first-page":"4042","DOI":"10.1002\/cncr.33032","volume":"126","author":"K Hueniken","year":"2020","unstructured":"Hueniken K, Douglas CM, Jethwa AR, Mirshams M, Eng L, Hope A, et al. Measuring financial toxicity incurred after treatment of head and neck cancer: development and validation of the Financial Index of Toxicity questionnaire. Cancer. 2020;126(17):4042\u201350.","journal-title":"Cancer"},{"issue":"6","key":"13230_CR14","doi-asserted-by":"publisher","first-page":"e466","DOI":"10.3747\/co.24.3543","volume":"24","author":"R Martino","year":"2017","unstructured":"Martino R, Ringash J, Durkin L, Greco E, Huang SH, Xu W, et al. Feasibility of assessing patient health benefits and incurred costs resulting from early dysphagia intervention during and immediately after chemoradiotherapy for head-and-neck cancer. Curr Oncol. 2017;24(6):e466\u201376.","journal-title":"Curr Oncol"},{"key":"13230_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/cancers13195015","volume":"13","author":"S Pauge","year":"2021","unstructured":"Pauge S, Surmann B, Mehlis K, Zueger A, Richter L, Menold N, et al. Patient-reported Financial Distress in Cancer: a systematic review of risk factors in Universal Healthcare systems. Cancers (Basel). 2021;13:19.","journal-title":"Cancers (Basel)"},{"key":"13230_CR16","doi-asserted-by":"publisher","first-page":"100423","DOI":"10.1016\/j.jcpo.2023.100423","volume":"36","author":"T Olivier","year":"2023","unstructured":"Olivier T, Haslam A, Prasad V. Is financial toxicity captured in quality of life assessments in oncology randomized clinical trials? J Cancer Policy. 2023;36:100423.","journal-title":"J Cancer Policy"},{"issue":"4","key":"13230_CR17","doi-asserted-by":"publisher","first-page":"e310","DOI":"10.1200\/JOP.2016.016337","volume":"13","author":"JA de Souza","year":"2017","unstructured":"de Souza JA, Kung S, O\u2019Connor J, Yap BJ. Determinants of patient-centered financial stress in patients with locally Advanced Head and Neck Cancer. J Oncol Pract. 2017;13(4):e310\u20138.","journal-title":"J Oncol Pract"},{"issue":"7","key":"13230_CR18","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1093\/annonc\/mdz140","volume":"30","author":"J Witte","year":"2019","unstructured":"Witte J, Mehlis K, Surmann B, Lingnau R, Damm O, Greiner W, et al. Methods for measuring financial toxicity after cancer diagnosis and treatment: a systematic review and its implications. Ann Oncol. 2019;30(7):1061\u201370.","journal-title":"Ann Oncol"},{"issue":"5","key":"13230_CR19","doi-asserted-by":"publisher","first-page":"356","DOI":"10.33546\/bnj.1927","volume":"7","author":"J Gunawan","year":"2021","unstructured":"Gunawan J, Marzilli C, Aungsuroch Y. Establishing appropriate sample size for developing and validating a questionnaire in nursing research. Belitung Nurs J. 2021;7(5):356\u201360. https:\/\/doi.org\/10.33546\/bnj.1927. PMID: 37496511; PMCID: PMC10367972.","journal-title":"Belitung Nurs J"},{"issue":"2","key":"13230_CR20","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1207\/s15327574ijt0502_4","volume":"5","author":"DJ Mundfrom","year":"2005","unstructured":"Mundfrom DJ, Shaw DG, Ke TL. Minimum sample size recommendations for conducting factor analyses. Int J Test. 2005;5(2):159\u201368. https:\/\/doi.org\/10.1207\/s15327574ijt0502_4","journal-title":"Int J Test"},{"key":"13230_CR21","doi-asserted-by":"publisher","first-page":"104521","DOI":"10.1016\/j.oraloncology.2019.104521","volume":"101","author":"WH Beeler","year":"2020","unstructured":"Beeler WH, Bellile EL, Casper KA, Jaworski E, Burger NJ, Malloy KM, et al. Patient-reported financial toxicity and adverse medical consequences in head and neck cancer. Oral Oncol. 2020;101:104521.","journal-title":"Oral Oncol"},{"issue":"1","key":"13230_CR22","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1186\/s12885-020-07028-4","volume":"20","author":"K Mehlis","year":"2020","unstructured":"Mehlis K, Witte J, Surmann B, Kudlich M, Apostolidis L, Walther J, et al. The patient-level effect of the cost of Cancer care - financial burden in German Cancer patients. BMC Cancer. 2020;20(1):529.","journal-title":"BMC Cancer"},{"issue":"1","key":"13230_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14639\/0392-100X-N2762","volume":"44","author":"E Raggini","year":"2024","unstructured":"Raggini E, Mattavelli D, Zigliani G, Bossi P, Piazza C. Measuring financial toxicity in head and neck cancer: a systematic review. Acta Otorhinolaryngol Ital. 2024;44(1):1\u201312.","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"13230_CR24","doi-asserted-by":"crossref","unstructured":"Farrugia M, Yu H, Ma SJ, Iovoli AJ, Erickson K, Wendel E et al. Financial Counseling is Associated with reduced Financial Difficulty scores in Head and Neck Cancer patients treated with Radiation Therapy. Cancers (Basel). 2021;13(11).","DOI":"10.3390\/cancers13112516"},{"issue":"5","key":"13230_CR25","doi-asserted-by":"publisher","first-page":"102992","DOI":"10.1016\/j.esmoop.2024.102992","volume":"9","author":"PM Carrera","year":"2024","unstructured":"Carrera PM, Curigliano G, Santini D, Sharp L, Chan RJ, Pisu M, et al. ESMO expert consensus statements on the screening and management of financial toxicity in patients with cancer. ESMO Open. 2024;9(5):102992.","journal-title":"ESMO Open"},{"key":"13230_CR26","unstructured":"De Lorenzo F, FDel C, Iannelli L. Indagine Sui costi sociali ed economici del cancro nel 2018 in 11 Rapporto sulla condizione assistenziale dei malati oncologici. Oncologia FFIdAdVi. 2018;1."},{"issue":"12","key":"13230_CR27","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1093\/annonc\/mdw433","volume":"27","author":"F Perrone","year":"2016","unstructured":"Perrone F, Jommi C, Di Maio M, Gimigliano A, Gridelli C, Pignata S, et al. The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in Italy. Ann Oncol. 2016;27(12):2224\u20139.","journal-title":"Ann Oncol"},{"issue":"10","key":"13230_CR28","doi-asserted-by":"publisher","first-page":"e049128","DOI":"10.1136\/bmjopen-2021-049128","volume":"11","author":"S Riva","year":"2021","unstructured":"Riva S, Arenare L, Di Maio M, Efficace F, Montesarchio V, Frontini L, et al. Cross-sectional study to develop and describe psychometric characteristics of a patient-reported instrument (PROFFIT) for measuring financial toxicity of cancer within a public healthcare system. BMJ Open. 2021;11(10):e049128.","journal-title":"BMJ Open"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-13230-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-13230-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-13230-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T03:01:09Z","timestamp":1739847669000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-13230-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13230"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-13230-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4313686\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,18]]},"assertion":[{"value":"23 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethical Committee of ASST Spedali Civili of Brescia (NP 5560). According to this approval, informed Consent Form was not required for the procedure of questionnaire development and validation since patients participated anonymously and no patient data was collected. Patients were asked to provide personal insights and experience with financial toxicity, and to evaluate the intelligibility and the completeness of the questions and answers of the questionnaire.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No\/Not applicable (this manuscript does not report data generation or analysis).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"283"}}